12:02 PM EST - Optimi Health : Reports that Health Canada has added the Company’s wholly-owned subsidiary Optimi Labs Inc. to a list of approved suppliers under the Special Access Program. With a mission to provide compassionate, frontline solutions to Canada’s growing mental health crisis, the Company plans to supply psychedelics like psilocybin to those truly in need. Optimi Health
shares C.OPTI are trading up $0.03 at $0.40.
